SINGULAR GENOMICS SYSTEMS IN (OMIC) Stock Price, Forecast & Analysis
USA - NASDAQ:OMIC - US82933R3084 - Common Stock
OMIC Key Statistics, Chart & Performance
The current stock price of OMIC is 20.01 USD. In the past month the price increased by 0.6%. In the past year, price increased by 21.27%.
OMIC Latest News, Press Relases and Analysis
OMIC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 25.27 | 213.72B | ||
| DHR | DANAHER CORP | 27.32 | 150.85B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 156.65 | 47.53B | ||
| A | AGILENT TECHNOLOGIES INC | 27.06 | 41.81B | ||
| IQV | IQVIA HOLDINGS INC | 18.13 | 35.85B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.2 | 29.66B | ||
| WAT | WATERS CORP | 29.23 | 22.09B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 38.94 | 19.80B | ||
| ILMN | ILLUMINA INC | 27.78 | 18.61B | ||
| MEDP | MEDPACE HOLDINGS INC | 41.41 | 16.63B | ||
| TEM | TEMPUS AI INC | N/A | 12.52B | ||
| ICLR | ICON PLC | 12.13 | 12.44B |
Related stock screener links
About OMIC
Company Profile
Singular Genomics Systems Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in San Diego, California and currently employs 255 full-time employees. The company went IPO on 2021-05-27. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. The firm has developed NGS technology (Sequencing Engine), which is a platform technology for its products. The core of its Sequencing Engine consists of proprietary chemistry, including novel chemical compounds, polymers, and enzymes. Its active product development pipeline consists of two products, each of which is designed to leverage the Sequencing Engine and purpose-built to address different applications. Its first product, the G4 Sequencing Platform (G4), targets the NGS market. Its second product in development, G4X Spatial Sequencer, which leverages its sequencing technology, applying it as an in-situ readout for transcriptomics, proteomics and fluorescent H&E in tissue, with spatial context and on the same platform as the G4. The firm is also engaged in developing PX, which is a development-stage multiomics platform.
Company Info
SINGULAR GENOMICS SYSTEMS IN
3010 Science Park Road
San Diego CALIFORNIA US
CEO: Andrew Spaventa
Employees: 255
Phone: 18583337830
SINGULAR GENOMICS SYSTEMS IN / OMIC FAQ
Can you describe the business of SINGULAR GENOMICS SYSTEMS IN?
Singular Genomics Systems Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in San Diego, California and currently employs 255 full-time employees. The company went IPO on 2021-05-27. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. The firm has developed NGS technology (Sequencing Engine), which is a platform technology for its products. The core of its Sequencing Engine consists of proprietary chemistry, including novel chemical compounds, polymers, and enzymes. Its active product development pipeline consists of two products, each of which is designed to leverage the Sequencing Engine and purpose-built to address different applications. Its first product, the G4 Sequencing Platform (G4), targets the NGS market. Its second product in development, G4X Spatial Sequencer, which leverages its sequencing technology, applying it as an in-situ readout for transcriptomics, proteomics and fluorescent H&E in tissue, with spatial context and on the same platform as the G4. The firm is also engaged in developing PX, which is a development-stage multiomics platform.
Can you provide the latest stock price for SINGULAR GENOMICS SYSTEMS IN?
The current stock price of OMIC is 20.01 USD. The price increased by 0.25% in the last trading session.
Does SINGULAR GENOMICS SYSTEMS IN pay dividends?
OMIC does not pay a dividend.
What is the ChartMill rating of SINGULAR GENOMICS SYSTEMS IN stock?
OMIC has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Would investing in SINGULAR GENOMICS SYSTEMS IN be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on OMIC.
How many employees does SINGULAR GENOMICS SYSTEMS IN have?
SINGULAR GENOMICS SYSTEMS IN (OMIC) currently has 255 employees.
What is the ownership structure of SINGULAR GENOMICS SYSTEMS IN (OMIC)?
You can find the ownership structure of SINGULAR GENOMICS SYSTEMS IN (OMIC) on the Ownership tab.
OMIC Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to OMIC. When comparing the yearly performance of all stocks, OMIC is one of the better performing stocks in the market, outperforming 75.64% of all stocks.
OMIC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to OMIC. The financial health of OMIC is average, but there are quite some concerns on its profitability.
OMIC Financial Highlights
Over the last trailing twelve months OMIC reported a non-GAAP Earnings per Share(EPS) of -35.09. The EPS increased by 8.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -46.27% | ||
| ROE | -70.04% | ||
| Debt/Equity | 0.04 |
OMIC Forecast & Estimates
8 analysts have analysed OMIC and the average price target is 12.7 USD. This implies a price decrease of -36.54% is expected in the next year compared to the current price of 20.01.
For the next year, analysts expect an EPS growth of 11.81% and a revenue growth 9.93% for OMIC